(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) is a potent, selective and irreversible NF-kappaB inhibitor that covalently binds to a cysteine residue. (-)-DHMEQ inhibits nuclear translocation of NF-kappaB and shows anti-inflammatory and anticancer activity[1][2][3].
Molecular Weight:
261.23
Purity:
99.81
CAS Number:
[287194-40-5]
Formula:
C13H11NO5
Target:
NF-kappaB
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted